Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: RAD001|DRUG: Placebo
Sponsor: German Breast Group
Collaborators: Novartis